SUBSCRIBE
SUBSCRIBE

Government

Business
CDC Confirms COVID-19 is Less Severe in Pediatric Patients
The CDC findings were based on an analysis of 2,572 known juvenile cases of COVID-19 that were part of a batch of 149,760 laboratory-confirmed COVID-19 cases.
April 7, 2020
 · 
2 min read
 · 
Alex Keown
Policy
Biopharma Update on the Novel Coronavirus: April 7
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 7, 2020.
April 7, 2020
 · 
6 min read
 · 
BioSpace Editorial Staff
Drug Development
Biopharma Update on the Novel Coronavirus: April 6
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 6, 2020.
April 6, 2020
 · 
6 min read
 · 
BioSpace Editorial Staff
Policy
Biopharma Update on the Novel Coronavirus: April 3
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 3, 2020.
April 3, 2020
 · 
6 min read
 · 
BioSpace Editorial Staff
FDA
FDA Approves 1st COVID-19 Antibody Test
The U.S. Food and Drug Administration approved the first blood test that looks for the antibodies against the novel coronavirus that causes COVID-19.
April 3, 2020
 · 
3 min read
 · 
Mark Terry
Business
Compare: 1918 Spanish Influenza Pandemic Versus COVID-19
With all the similarities, it should be emphasized that there are several significant differences between the two pandemics.
April 2, 2020
 · 
9 min read
 · 
Mark Terry
Drug Development
Biopharma Update on the Novel Coronavirus: April 2
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 2, 2020.
April 2, 2020
 · 
7 min read
 · 
BioSpace Editorial Staff
Policy
As COVID-19 Cases Rise, FDA Accelerates Development of Therapies
The U.S. Food and Drug Administration is expediting the development of novel therapies for the pandemic through an accelerated evaluation process.
April 1, 2020
 · 
2 min read
 · 
Alex Keown
photobyphm/Shutterstock
Policy
FDA Ends Zolgensma Data Manipulation Investigation, Places No Penalties on Novartis
In a statement, the FDA said “objectionable conditions were found and documented” but did not meet the threshold for regulatory action against the Swiss pharma giant.
April 1, 2020
 · 
2 min read
 · 
Alex Keown
Policy
Biopharma Update on the Novel Coronavirus: April 1
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 1, 2020.
April 1, 2020
 · 
8 min read
 · 
BioSpace Editorial Staff
Load More
PRESS RELEASES
Policy
FDA takes new steps to encourage the development of novel medicines for the treatment of opioid use disorder
August 6, 2018
 · 
6 min read
Policy
Information Update - Unauthorized workout and sexual enhancement supplements seized from “Edge Nutrition” in Windsor, ON, because they may pose serious health risks
August 3, 2018
 · 
7 min read
Stryker Nabs FDA OK for Cementless Mako Total Knee
FDA
Statement from FDA Commissioner Scott Gottlieb, M.D., on new steps the agency is taking to support the development of novel nicotine replacement drug therapies to help smokers quit cigarettes
August 3, 2018
 · 
6 min read
Policy
Kidney Patients with Alport Syndrome are Center of FDA Patient-Focused Meeting
August 3, 2018
 · 
4 min read
Policy
Canadian Clinicians for Therapeutic Nutrition Identify Shortcomings in Health Canada’s Approach to Dietary Guidelines Revision
August 2, 2018
 · 
4 min read
Policy
Advisory -"Jian Pai Natural Skin Care Cream” contains antifungal drugs not listed on the label, which may pose serious health risks
August 2, 2018
 · 
2 min read
Business
IAVI and the Public Health Agency of Canada Enter into License Agreement for Technology to Enable Lassa Fever Vaccine Development
August 2, 2018
 · 
6 min read
Policy
Parata Renews Authorization to Operate by the Defense Health Agency
August 2, 2018
 · 
2 min read
Policy
Advisory - Unauthorized skin creams and lotions sold at various retailers in Quebec may pose serious health risks
August 1, 2018
 · 
4 min read
Policy
Contact Lens Care: You’re Probably Doing It Wrong
August 1, 2018
 · 
4 min read
Policy
Statement from FDA Commissioner Scott Gottlieb, M.D., on FDA’s continued, careful oversight of the REMS associated with transmucosal immediate-release fentanyl products
August 1, 2018
 · 
6 min read
Business
Prince William County Reports Over 300 New Jobs and $33 Million in Intended Capital Investment from Economic Development Projects in the First Half of 2018
August 1, 2018
 · 
2 min read
Drug Development
National Institutes of Health Awards Magnetic Insight with a $1.5M Phase II SBIR grant to support the first commercial multimodal preclinical magnetic particle imaging system
August 1, 2018
 · 
2 min read
Policy
Information Update - Health Canada updates Canadians on shortage situation involving EpiPen (0.3 mg) auto-injectors
July 30, 2018
 · 
2 min read
Policy
FDA approves first treatment for rare adrenal tumors
July 30, 2018
 · 
4 min read
Policy
Statement from FDA Commissioner Scott Gottlieb, M.D., on efforts to safeguard women’s health from deceptive health claims and significant risks related to devices marketed for use in medical procedures for “vaginal rejuvenation”
July 30, 2018
 · 
5 min read
Policy
Smoke-Free Housing To Protect Millions From The Dangers Of Secondhand Smoke To Take Effect July 31
July 30, 2018
 · 
1 min read
Policy
Striking workers to present resolution to City Council
July 30, 2018
 · 
2 min read
Policy
Safety Of Unadulterated Kratom Affirmed By The National Institute Of Drug Abuse
July 30, 2018
 · 
3 min read
Policy
CHI Founder Ann Armstrong-Dailey Applauds the Reintroduction of the ChiPACC Act of 2018
July 27, 2018
 · 
3 min read
Load More